Zheng C et al. |
Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. |
2010 |
Am. J. Respir. Cell Mol. Biol. |
pmid:20118222
|
Xu X et al. |
Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. |
2010 |
Diabetes |
pmid:20068141
|
Liu JY et al. |
Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. |
2010 |
Biochem. Pharmacol. |
pmid:19896470
|
Zhang W et al. |
Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. |
2009 |
J. Cereb. Blood Flow Metab. |
pmid:19471280
|
Shen HC et al. |
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors. |
2009 |
Bioorg. Med. Chem. Lett. |
pmid:19682899
|
Ghosh S et al. |
Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. |
2008 |
Basic Clin. Pharmacol. Toxicol. |
pmid:18312493
|
Ng VY et al. |
Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. |
2007 |
Drug Metab. Dispos. |
pmid:17431031
|
Fang X et al. |
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. |
2006 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16113065
|
Gauthier KM et al. |
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15528233
|
Spiecker M et al. |
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. |
2004 |
Circulation |
pmid:15466638
|